CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-12 | EcoR1 Capital, LLC 10% owner | Purchase | +62,500 | $20.50 | $1.3M | 9,489,140 |
| 2021-02-12 | EcoR1 Capital, LLC 10% owner | Purchase | +282,800 | $20.08 | $5.7M | 9,771,940 |
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Option exercise | +7,560 | $6.41 | $48K | 7,560 |
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Sale | −7,560 | $17.07 | $129K | 0 |
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Option exercise | +18,750 | $13.53 | $254K | 18,750 |
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Sale | −18,750 | $20.00 | $375K | 0 |
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −7,560 | 7,540 | ||
| 2021-02-12 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −18,750 | 31,250 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Returned to the company · Employee Stock Option (Right to Buy) | −55,000 | 0 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Returned to the company · Employee Stock Option (Right to Buy) | −65,000 | 0 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +40,625 | 40,625 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Returned to the company · Employee Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +39,062 | 39,062 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Returned to the company · Employee Stock Option (Right to Buy) | −80,000 | 0 | ||
| 2021-02-12 | Nguyen Tran See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +60,150 | 60,150 | ||
| 2021-02-12 | Cooke Shane Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | Cooke Shane Director | Grant or award · Employee Stock Option (Right to Buy) | +9,803 | 9,803 | ||
| 2021-02-12 | Cooke Shane Director | Returned to the company · Employee Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2021-02-12 | Cooke Shane Director | Grant or award · Employee Stock Option (Right to Buy) | +8,426 | 8,426 |
Page 36 of 41 · 819 trades